Michael Carrier
Stock Analyst at Oppenheimer
(3.10)
# 1,240
Out of 4,711 analysts
227
Total ratings
69.62%
Success rate
19.91%
Average return
Main Sectors:
Stocks Rated by Michael Carrier
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHAR Pharming Group | Maintains: Outperform | $31 → $30 | $9.10 | +229.67% | 2 | Oct 28, 2024 | |
| NTRS Northern Trust | Maintains: Buy | $103 → $115 | $102.48 | +12.22% | 12 | Oct 24, 2024 | |
| TW Tradeweb Markets | Maintains: Buy | $134 → $139 | $132.73 | +4.72% | 6 | Oct 3, 2024 | |
| CBOE Cboe Global Markets | Maintains: Buy | $200 → $204 | $192.49 | +5.98% | 17 | Apr 19, 2024 | |
| MS Morgan Stanley | Maintains: Buy | $100 → $106 | $123.44 | -14.13% | 11 | Apr 17, 2024 | |
| GS The Goldman Sachs Group | Downgrades: Neutral | $490 → $475 | $566.10 | -16.09% | 6 | Jan 6, 2022 | |
| AB AllianceBernstein Holding L.P. | Downgrades: Neutral | $42 | $37.26 | +12.72% | 12 | Apr 9, 2021 | |
| VCTR Victory Capital Holdings | Upgrades: Buy | $24 → $32 | $65.46 | -51.12% | 4 | Apr 9, 2021 | |
| BSIG BrightSphere Investment Group | Upgrades: Buy | $22 → $27 | $27.01 | -0.04% | 5 | Apr 9, 2021 | |
| BK BNY Mellon | Upgrades: Buy | $43 → $50 | $77.62 | -35.58% | 10 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $200 → $220 | $238.53 | -7.77% | 10 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $19 → $14 | $9.92 | +41.13% | 1 | Mar 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $68 | $74.31 | -8.49% | 9 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $154 | $116.12 | +32.62% | 9 | Nov 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $76 | $92.49 | -17.83% | 9 | Nov 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $26 | $20.49 | +26.89% | 9 | Oct 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $71 → $70 | $98.20 | -28.72% | 10 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $633 → $675 | $1,028.69 | -34.38% | 6 | Jul 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $154 | $221.00 | -30.32% | 7 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $17.33 | -36.53% | 6 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $70 → $71 | $182.53 | -61.10% | 5 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $40 | $147.58 | -72.90% | 6 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $25 → $27 | $50.22 | -46.24% | 10 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $62 → $58 | $170.84 | -66.05% | 5 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $44 | $176.04 | -75.01% | 7 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $54 → $53 | $171.03 | -69.01% | 3 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $47 | $77.70 | -39.94% | 7 | Jul 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $20.29 | - | 4 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $17 → $13 | $42.55 | -69.45% | 2 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $22 → $15 | $41.05 | -63.46% | 1 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $23 → $18 | $43.74 | -58.85% | 3 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $81 | $150.31 | -46.11% | 4 | Mar 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $57 → $39 | $1.12 | +3,382.14% | 9 | Oct 2, 2019 |
Pharming Group
Oct 28, 2024
Maintains: Outperform
Price Target: $31 → $30
Current: $9.10
Upside: +229.67%
Northern Trust
Oct 24, 2024
Maintains: Buy
Price Target: $103 → $115
Current: $102.48
Upside: +12.22%
Tradeweb Markets
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $139
Current: $132.73
Upside: +4.72%
Cboe Global Markets
Apr 19, 2024
Maintains: Buy
Price Target: $200 → $204
Current: $192.49
Upside: +5.98%
Morgan Stanley
Apr 17, 2024
Maintains: Buy
Price Target: $100 → $106
Current: $123.44
Upside: -14.13%
The Goldman Sachs Group
Jan 6, 2022
Downgrades: Neutral
Price Target: $490 → $475
Current: $566.10
Upside: -16.09%
AllianceBernstein Holding L.P.
Apr 9, 2021
Downgrades: Neutral
Price Target: $42
Current: $37.26
Upside: +12.72%
Victory Capital Holdings
Apr 9, 2021
Upgrades: Buy
Price Target: $24 → $32
Current: $65.46
Upside: -51.12%
BrightSphere Investment Group
Apr 9, 2021
Upgrades: Buy
Price Target: $22 → $27
Current: $27.01
Upside: -0.04%
BNY Mellon
Mar 24, 2021
Upgrades: Buy
Price Target: $43 → $50
Current: $77.62
Upside: -35.58%
Mar 24, 2021
Upgrades: Buy
Price Target: $200 → $220
Current: $238.53
Upside: -7.77%
Mar 24, 2021
Downgrades: Underperform
Price Target: $19 → $14
Current: $9.92
Upside: +41.13%
Jan 12, 2021
Upgrades: Buy
Price Target: $68
Current: $74.31
Upside: -8.49%
Nov 19, 2020
Downgrades: Neutral
Price Target: $154
Current: $116.12
Upside: +32.62%
Nov 19, 2020
Upgrades: Buy
Price Target: $76
Current: $92.49
Upside: -17.83%
Oct 9, 2020
Upgrades: Buy
Price Target: $26
Current: $20.49
Upside: +26.89%
Jul 20, 2020
Maintains: Buy
Price Target: $71 → $70
Current: $98.20
Upside: -28.72%
Jul 20, 2020
Maintains: Buy
Price Target: $633 → $675
Current: $1,028.69
Upside: -34.38%
Jul 10, 2020
Maintains: Buy
Price Target: $140 → $154
Current: $221.00
Upside: -30.32%
Jul 10, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $17.33
Upside: -36.53%
Jul 10, 2020
Maintains: Underperform
Price Target: $70 → $71
Current: $182.53
Upside: -61.10%
Jul 10, 2020
Maintains: Buy
Price Target: $36 → $40
Current: $147.58
Upside: -72.90%
Jul 10, 2020
Maintains: Underperform
Price Target: $25 → $27
Current: $50.22
Upside: -46.24%
Jul 10, 2020
Maintains: Neutral
Price Target: $62 → $58
Current: $170.84
Upside: -66.05%
Jul 10, 2020
Maintains: Buy
Price Target: $43 → $44
Current: $176.04
Upside: -75.01%
Jul 10, 2020
Maintains: Neutral
Price Target: $54 → $53
Current: $171.03
Upside: -69.01%
Jul 10, 2020
Maintains: Buy
Price Target: $43 → $47
Current: $77.70
Upside: -39.94%
Mar 24, 2020
Downgrades: Perform
Price Target: n/a
Current: $20.29
Upside: -
Mar 23, 2020
Maintains: Underperform
Price Target: $17 → $13
Current: $42.55
Upside: -69.45%
Mar 23, 2020
Maintains: Underperform
Price Target: $22 → $15
Current: $41.05
Upside: -63.46%
Mar 23, 2020
Maintains: Underperform
Price Target: $23 → $18
Current: $43.74
Upside: -58.85%
Mar 23, 2020
Maintains: Buy
Price Target: $99 → $81
Current: $150.31
Upside: -46.11%
Oct 2, 2019
Downgrades: Underperform
Price Target: $57 → $39
Current: $1.12
Upside: +3,382.14%